Nanowear
About Nanowear
Nanowear is the leading developer of patented, textile-based nanosensor technology with applications across a broad array of medical conditions and chronic disease states. The Company’s proprietary technology provides medical professionals with accurate and continuous diagnostic data through a wearable deployment that is cost-effective and unobtrusive to the patient. Real-time data is captured and transmitted wirelessly, streamlining the feedback process and driving outcomes. Nanowear’s core focus on innovation and next-gen technologies will continue to propel the Company towards exploring unique and groundbreaking applications for its nanosensor smart-textile technology.YEAR FOUNDED:
2014
LEADERSHIP:
Co-Founder & CEO: Venk Varadan
Co-Founder, Inventor & CINO: Dr. Vijay Varadan
CMO: John Zimmerman M.D.
Founding Engineer & CTO: Prashanth Shyam Kumar
6 articles about Nanowear
-
Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management: SimpleSense-BP
1/4/2024
Nanowear has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-Medical Device (SaMD).
-
Nanowear Receives FDA 510(k) Platform Clearance to Implement Forthcoming AI-based Diagnostics in its Closed Loop Hospital-at-Home Network
9/28/2021
Nanowear, a leading hospital-at-home and remote diagnostic platform informed by proprietary cloth nanotechnology and AI, today announced that it received its third FDA 510(k) clearance and first software-only clearance as an end-to-end digital platform, illustrating unique capabilities available to enterprise customer channels across a broad spectrum of diagnostic and monitoring verticals.
-
Nanowear Announces COVID-19 Remote Diagnostic Research Collaboration with New York City-Metro Health Systems
7/22/2020
Nanowear www.nanowearinc.com , the leading nanotechnology-based connected-care and remote diagnostic platform, today announced an expanded COVID-19 remote diagnostic research alliance with Hackensack Meridian Health Systems, the largest hospital system in New Jersey and Maimonides Medical Center in Brooklyn, NY .
-
Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study
7/22/2019
Nanowear, the leading nanotechnology-based connected-care and remote monitoring platform, today announced the clinical launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study
-
Nanowear and The Secant Group Announce Exclusive Supply Chain Partnership for Scaled Manufacturing of Proprietary Cloth-Based Nanosensor Technology
1/5/2018
Under the terms of the agreement, Nanowear and The Secant Group will have the collective obligation for marketing the technology and associated products.
-
Nanowear Wins FDA OK for its Transformative Remote Diagnostic Monitoring Device
12/2/2016